Medicine recalls
|
| |
| Canada: JAMP Digoxin tablets: One lot recalled due to possible oversized tablets which may pose overdose risk |
| |
Health Canada announces that JAMP Pharma Corporation is recalling one lot of JAMP Digoxin 0.0625 mg tablets (lot number: EG23DGX001) as some bottles may contain thicker, oversized tablets. Patients taking an oversized tablet will unexpectedly receive a higher dose than intended, which may pose serious health risks, including overdose. Digoxin is a drug where small differences in dose or blood concentration can lead to side effects, therefore it is very important that all patients taking the affected JAMP product return it to the pharmacy for replacement.
JAMP Digoxin is a prescription drug used in children and adults to treat mild to moderate congestive heart failure. It can also be used to treat a fast or irregular heartbeat (e.g., atrial fibrillation).
Signs and symptoms of a digoxin overdose may include nausea, vomiting, decreased appetite, diarrhea, confusion, seizures, hallucinations, vision effects (seeing light "halos" around objects, or green or yellow vision), fatigue, irregular heartbeat, and abnormally fast or slow heartbeat. In cases of severe overdose, heart-related effects could be life threatening. Children, people over the age of 65, and people who have an electrolyte or thyroid disorder may be at a higher risk of adverse effects.
Health Canada is monitoring the company's recall and its implementation of any necessary corrective and preventative actions to stop this issue from reoccurring.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/jamp-digoxin-tablets-one-lot-recalled-due-possible-oversized-tablets-which-may-pose
Local Situation in Hong Kong: In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/ Saturday, June 01, 2024
Issued at HKT 12:00
|
| |
